Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications
Top Cited Papers
- 20 August 2010
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 1 (3) , 183-198
Abstract
In 2003, bortezomib, a first-in-class therapeutic, gained approval from the US Federal Drug Administration for the treatment of relapsed multiple myeloma and mantle cell lymphoma. Approval in the UK, for multiple myeloma, followed in 2006. Bortezomib contains a boronic acid, a functional group that has become increasingly more commonplace within the medicinal chemistry literature. The introduction of this drug has sparked a renewed interest in the investigation of boronic acids as drugs for a wide range of diseases. This review will guide the reader through the most recent developments in this field, by considering in turn, the biological target's amenable to the action of boronic acids.Keywords
This publication has 107 references indexed in Scilit:
- A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agentBioorganic & Medicinal Chemistry, 2010
- Multivalent Benzoboroxole Functionalized Polymers as gp120 Glycan Targeted Microbicide Entry InhibitorsMolecular Pharmaceutics, 2009
- Potent and Selective Peptidyl Boronic Acid Inhibitors of the Serine Protease Prostate-Specific AntigenChemistry & Biology, 2008
- The penicillin-binding proteins: structure and role in peptidoglycan biosynthesisFEMS Microbiology Reviews, 2008
- Structure-based optimization of cephalothin-analogue boronic acids as β-lactamase inhibitorsBioorganic & Medicinal Chemistry, 2008
- Use of Novel Boronic Acid Transition State Inhibitors To Probe Substrate Affinity in SHV-Type Extended-Spectrum β-LactamasesAntimicrobial Agents and Chemotherapy, 2007
- Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophoresProceedings of the National Academy of Sciences, 2007
- Role of Asp104 in the SHV β-LactamaseAntimicrobial Agents and Chemotherapy, 2006
- Structure of 20S proteasome from yeast at 2.4Å resolutionNature, 1997
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990